Effects of Adding Intravenous Pamidronate to Ongoing Menopausal Hormone Therapy in Postmenopausal Korean Women with Low Bone Mineral Density.

J Menopausal Med · 2019 · PMC6952709 · PMID 32307936

Europe PMC DOI

hedged sentences

0.0970

closest p · 1.9× alpha

0.0970

boldest claim

The sentences

marginal significanceP = 0.097so close (0.05 < p ≤ 0.1)

4.6%) with marginal significance before and after adjustment of baseline BMI and duration of previous MHT ( P = 0.097 and P = 0.062, respectively).

also in 5,069 other papers

did not reach statistical significanceno p-value reported

Hip BMD values were also increased with pamidronate for 12 months but did not reach statistical significance compared with the control group.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.